0 16 April 2025 false false false false false false false false false false true false false false false false false No description of principal activity 2023-04-01 Sage Accounts Production Advanced 2023 - FRS102_2023 4,624,088 49,662 92,482 142,144 4,481,944 4,574,426 100 100 100 xbrli:pure xbrli:shares iso4217:GBP 12276975 2023-04-01 2024-03-30 12276975 2024-03-30 12276975 2023-03-31 12276975 2022-04-01 2023-03-31 12276975 2023-03-31 12276975 2022-03-31 12276975 bus:OrdinaryShareClass1 2023-04-01 2024-03-30 12276975 bus:Director3 2023-04-01 2024-03-30 12276975 bus:Director1 2023-04-01 2024-03-30 12276975 core:WithinOneYear 2024-03-30 12276975 core:WithinOneYear 2023-03-31 12276975 core:LandBuildings core:LongLeaseholdAssets 2023-03-31 12276975 core:LandBuildings core:LongLeaseholdAssets 2024-03-30 12276975 core:AfterOneYear 2024-03-30 12276975 core:AfterOneYear 2023-03-31 12276975 core:ShareCapital 2024-03-30 12276975 core:ShareCapital 2023-03-31 12276975 core:RetainedEarningsAccumulatedLosses 2024-03-30 12276975 core:RetainedEarningsAccumulatedLosses 2023-03-31 12276975 core:LandBuildings core:LongLeaseholdAssets 2023-04-01 2024-03-30 12276975 core:CostValuation core:Non-currentFinancialInstruments 2024-03-30 12276975 core:Non-currentFinancialInstruments 2024-03-30 12276975 core:Non-currentFinancialInstruments 2023-03-31 12276975 core:BetweenOneFiveYears 2024-03-30 12276975 core:BetweenOneFiveYears 2023-03-31 12276975 core:MoreThanFiveYears 2024-03-30 12276975 core:MoreThanFiveYears 2023-03-31 12276975 core:LandBuildings core:LongLeaseholdAssets 2023-03-31 12276975 bus:Director1 2023-03-31 12276975 bus:Director1 2024-03-30 12276975 bus:Director1 2023-03-31 12276975 bus:Director1 2022-04-01 2023-03-31 12276975 bus:SmallEntities 2023-04-01 2024-03-30 12276975 bus:Audited 2023-04-01 2024-03-30 12276975 bus:SmallCompaniesRegimeForAccounts 2023-04-01 2024-03-30 12276975 bus:PrivateLimitedCompanyLtd 2023-04-01 2024-03-30 12276975 bus:FullAccounts 2023-04-01 2024-03-30 12276975 bus:OrdinaryShareClass1 2024-03-30 12276975 bus:OrdinaryShareClass1 2023-03-31 12276975 core:AfterOneYear 2023-04-01 2024-03-30
COMPANY REGISTRATION NUMBER: 12276975
Impression Health and Support Chester Limited
Filleted Financial Statements
30 March 2024
Impression Health and Support Chester Limited
Statement of Financial Position
30 March 2024
2024
2023
Note
£
£
Fixed assets
Tangible assets
4
4,481,944
4,574,426
Investments
5
100
100
------------
------------
4,482,044
4,574,526
Current assets
Debtors
6
611,559
46,161
Cash at bank and in hand
100
100
---------
--------
611,659
46,261
Creditors: amounts falling due within one year
7
773,864
277,472
---------
---------
Net current liabilities
162,205
231,211
------------
------------
Total assets less current liabilities
4,319,839
4,343,315
Creditors: amounts falling due after more than one year
8
4,356,070
4,314,592
------------
------------
Net (liabilities)/assets
( 36,231)
28,723
------------
------------
Capital and reserves
Called up share capital
9
100
100
Profit and loss account
( 36,331)
28,623
--------
--------
Shareholders (deficit)/funds
( 36,231)
28,723
--------
--------
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
In accordance with section 444 of the Companies Act 2006, the statement of income and retained earnings has not been delivered.
The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.
These financial statements were approved by the board of directors and authorised for issue on 16 April 2025 , and are signed on behalf of the board by:
Mr GJ Maloney
Director
Company registration number: 12276975
Impression Health and Support Chester Limited
Notes to the Financial Statements
Period ended 30 March 2024
1. General information
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is Sycamore House, Sutton Quays Business Park, Sutton Weaver, Runcorn, Cheshire, WA7 3EH.
2. Statement of compliance
These financial statements have been prepared in compliance with Section 1A of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.
3. Accounting policies
Basis of preparation
The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.
The financial statements are prepared in sterling, which is the functional currency of the entity.
Going concern
The company has made a loss before tax of £64,954 during the financial year and has net liabilities of £36,231 at the period end. However, the financial statements have been prepared on a going concern basis following information received from the directors regarding forecasted future profits. The accounts do not include adjustments that would be necessary if the company was unable to continue as a going concern.
Judgements and key sources of estimation uncertainty
The preparation of the financial statements requires management to make judgements, estimates and assumptions that affect the amounts reported. These estimates and judgements are continually reviewed and are based on experience and other factors, including expectations of future events that are believed to be reasonable under the circumstances.
Revenue recognition
Turnover is measured at the fair value of the consideration received or receivable for goods supplied and services rendered, net of discounts and Value Added Tax. Revenue from the sale of goods is recognised when the significant risks and rewards of ownership have transferred to the buyer (usually on despatch of the goods); the amount of revenue can be measured reliably; it is probable that the associated economic benefits will flow to the entity; and the costs incurred or to be incurred in respect of the transactions can be measured reliably.
Operating leases
Lease income is recognised in profit or loss on a straight line basis over the lease term. The aggregate cost of lease incentives are recognised as a reduction to income over the lease term on a straight-line basis. Costs, including depreciation, incurred in earning the lease income are recognised as an expense. Any initial direct costs incurred in negotiating and arranging the operating lease are added to the carrying amount of the lease and recognised as an expense over the lease term on the same basis as the lease income.
Tangible assets
Tangible assets are initially recorded at cost, and subsequently stated at cost less any accumulated depreciation and impairment losses. Any tangible assets carried at revalued amounts are recorded at the fair value at the date of revaluation less any subsequent accumulated depreciation and subsequent accumulated impairment losses. An increase in the carrying amount of an asset as a result of a revaluation, is recognised in other comprehensive income and accumulated in equity, except to the extent it reverses a revaluation decrease of the same asset previously recognised in profit or loss. A decrease in the carrying amount of an asset as a result of revaluation, is recognised in other comprehensive income to the extent of any previously recognised revaluation increase accumulated in equity in respect of that asset. Where a revaluation decrease exceeds the accumulated revaluation gains accumulated in equity in respect of that asset, the excess shall be recognised in profit or loss.
Depreciation
Depreciation is calculated so as to write off the cost or valuation of an asset, less its residual value, over the useful economic life of that asset as follows:
Long leasehold property
-
50 years straight line
Investments
Fixed asset investments are initially recorded at cost, and subsequently stated at cost less any accumulated impairment losses.
Listed investments are measured at fair value with changes in fair value being recognised in profit or loss.
Investments in associates
Investments in associates accounted for in accordance with the cost model are recorded at cost less any accumulated impairment losses. Investments in associates accounted for in accordance with the fair value model are initially recorded at the transaction price. At each reporting date, the investments are measured at fair value, with changes in fair value recognised in other comprehensive income/profit or loss. Where it is impracticable to measure fair value reliably without undue cost or effort, the cost model will be adopted. Dividends and other distributions received from the investment are recognised as income without regard to whether the distributions are from accumulated profits of the associate arising before or after the date of acquisition.
Investments in joint ventures
Investments in jointly controlled entities accounted for in accordance with the cost model are recorded at cost less any accumulated impairment losses. Investments in jointly controlled entities accounted for in accordance with the fair value model are initially recorded at the transaction price. At each reporting date, the investments are measured at fair value, with changes in fair value recognised in other comprehensive income/profit or loss. Where it is impracticable to measure fair value reliably without undue cost or effort, the cost model will be adopted. Dividends and other distributions received from the investment are recognised as income without regard to whether the distributions are from accumulated profits of the joint venture arising before or after the date of acquisition.
Impairment of fixed assets
A review for indicators of impairment is carried out at each reporting date, with the recoverable amount being estimated where such indicators exist. Where the carrying value exceeds the recoverable amount, the asset is impaired accordingly. Prior impairments are also reviewed for possible reversal at each reporting date. For the purposes of impairment testing, when it is not possible to estimate the recoverable amount of an individual asset, an estimate is made of the recoverable amount of the cash-generating unit to which the asset belongs. The cash-generating unit is the smallest identifiable group of assets that includes the asset and generates cash inflows that largely independent of the cash inflows from other assets or groups of assets. For impairment testing of goodwill, the goodwill acquired in a business combination is, from the acquisition date, allocated to each of the cash-generating units that are expected to benefit from the synergies of the combination, irrespective of whether other assets or liabilities of the company are assigned to those units.
Financial instruments
The company only has financial assets and financial liabilities of a kind that qualify as basic financial instruments. Basic financial instruments are initially recognised at transaction value and subsequently measured at their settlement value with the exception of bank loans which are subsequently measured at amortised cost using the effective interest method.
Debtors
Short term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.
Creditors
Short term trade creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.
4. Tangible assets
Long leasehold property
£
Cost
At 1 April 2023 and 30 March 2024
4,624,088
------------
Depreciation
At 1 April 2023
49,662
Charge for the period
92,482
------------
At 30 March 2024
142,144
------------
Carrying amount
At 30 March 2024
4,481,944
------------
At 31 March 2023
4,574,426
------------
5. Investments
Shares in group undertakings
£
Cost
At 1 April 2023 and 30 March 2024
100
----
Impairment
At 1 April 2023 and 30 March 2024
----
Carrying amount
At 30 March 2024
100
----
At 31 March 2023
100
----
6. Debtors
2024
2023
£
£
Amounts owed by group undertakings
611,151
46,161
Other debtors
408
---------
--------
611,559
46,161
---------
--------
7. Creditors: amounts falling due within one year
2024
2023
£
£
Bank loans and overdrafts
95,038
227,084
Amounts owed to group undertakings
657,451
46,113
Accruals and deferred income
20,700
3,600
Director loan accounts
675
675
---------
---------
773,864
277,472
---------
---------
8. Creditors: amounts falling due after more than one year
2024
2023
£
£
Bank loans and overdrafts
4,356,070
4,314,592
------------
------------
Included within creditors: amounts falling due after more than one year is an amount of £3,976,070 (2023: £3,406,257) in respect of liabilities payable or repayable by instalments which fall due for payment after more than five years from the reporting date.
There is a fixed and floating charge dated 16 September 2022 covering all property or undertaking of the company held by Cynergy Bank Limited.
9. Called up share capital
Issued, called up and fully paid
2024
2023
No.
£
No.
£
Ordinary shares of £ 1 each
100
100
100
100
----
----
----
----
10. Operating leases
As lessor
The total future minimum lease payments receivable under non-cancellable operating leases are as follows:
2024
2023
£
£
Not later than 1 year
450,000
450,000
Later than 1 year and not later than 5 years
1,800,000
1,800,000
Later than 5 years
1,557,123
2,007,123
------------
------------
3,807,123
4,257,123
------------
------------
11. Summary audit opinion
The auditor's report dated 16 April 2025 was unqualified , however, the auditor drew attention to the following by way of emphasis.
In forming our opinion on the financial statements, which is not qualified, we have considered the adequacy of the disclosure made in the accounting policies concerning the company's ability to continue as a going concern. The company made a net loss before tax of £64,954 during the period ended 30 March 2024 and at that date the company had net liabilities of £36,231. The other companies within Impression group have confirmed their support of the company should it be required. The financial statements do not include the adjustments that would result if the company was unable to continue as a going concern.
The senior statutory auditor was Simon McLean FCA , for and on behalf of AGP .
12. Directors' advances, credits and guarantees
During the period the directors entered into the following advances and credits with the company:
2024
Balance brought forward
Advances/ (credits) to the directors
Balance outstanding
£
£
£
Mr M Begg
( 675)
( 675)
----
----
----
2023
Balance brought forward
Advances/ (credits) to the directors
Balance outstanding
£
£
£
Mr M Begg
( 675)
( 675)
----
----
----
13. Controlling party
100% of the issued share capital is owned by Impression Health and Support UK Limited, a company registered in England and Wales. The ultimate controlling party is M Begg by virtue of his majority shareholding in the parent company, Impression Health and Support UK Limited. Copies of the consolidated financial statements of the Impression Health and Support UK Limited group are available to the public and may be obtained from Companies House.